Q3 Earnings News
Most Popular Q3 Earnings Story
Abbott Labs ($ABT) - Big Pharma's Q3 2010 Earnings Report
FiercePharma says: Citing its purchase of Solvay Pharmaceuticals and removing Meridia from the U.S. and Canadian markets, Abbott Labs' net income dropped 40 percent this quarter. Total earnings were Read more...
Latest Headlines
- November 4, 2010
- November 4, 2010
- November 4, 2010
- November 4, 2010
- November 4, 2010
- November 4, 2010
- November 4, 2010
- November 4, 2010
- November 4, 2010
- November 3, 2010
- November 2, 2010
- October 29, 2010
- October 28, 2010
- October 27, 2010
- November 2, 2009
- October 9, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
